Dactinomycin News
Dactinomycin currently has 0 news articles, with 9 predicted indications.
This page combines the AI-predicted indications for Dactinomycin with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (9):
- relapsing-remitting multiple sclerosis (99.6%)
- botryoid-type embryonal rhabdomyosarcoma of the vagina (99.5%)
- extrahepatic bile duct rhabdomyosarcoma (99.5%)
- embryonal extrahepatic bile duct rhabdomyosarcoma (99.5%)
- parameningeal embryonal rhabdomyosarcoma (99.5%)
- prostate embryonal rhabdomyosarcoma (99.5%)
- liver sarcoma (99.4%)
- upper aerodigestive tract neoplasm (99.2%)
- head and neck cancer (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.